Keyword Analysis & Research: cancer news

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
cancer news0.40.583238411
cancer0.260.61766346
news0.550.66277754

Keyword Research: People who searched cancer news also searched

Keyword CPC PCC Volume Score
cancer news1.80.4101338
cancer news today0.810.7111147
cancer news every 5 mins today0.070.4863117
cancer newsletter1.350.8817423
cancer news 20231.50.9127277
cancer news paper0.991133075
cancer news articles0.590.472349
cancer news india1.721369091
cancer news uk1.420.8499063
cancer news update1.720.310684
cancer news in hindi today0.120.6593551
cancer newspaper articles0.370.278471
cancer news medicalxpress0.890.2676718
cancer news every 5 mins0.30.442144
lung cancer news11412746
breast cancer news1.040.7213448
prostate cancer treatment latest news0.620.93742
triple negative breast cancer news1.480.719676
king charles cancer news1.110.4374065
latest breast cancer news0.350.9700635
latest prostate cancer news0.40.3387062
kate middleton news cancer1.90.1624618

Search Results related to cancer news on Search Engine

  • Personalized Vaccine for Liver Cancer Shows Promise in Clinical …

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/newsroom/news-releases/2024/04/personalized-vaccine-for-liver-cancer-shows-promise-in-clinical-trial

    WEBApr 4, 2024 · Fast Facts. Click to Tweet. Global clinical trial led by @hopkinskimmel investigators finds personalized anti-tumor vaccine plus immunotherapy improves outcomes for liver cancers. Adding a personalized anti-tumor vaccine to standard immunotherapy is safe and about twice as likely to shrink cancer as standard immunotherapy alone for …

    DA: 71 PA: 52 MOZ Rank: 7

  • Novel Drug Combination Shows Promise for Advanced HER2 …

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/newsroom/news-releases/2024/02/novel-drug-combination-shows-promise-for-advanced-her2-negative-breast-cancer

    WEBFeb 14, 2024 · A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center. The treatment included a histone deacetylase (HDAC) inhibitor — a drug that causes a chemical change to stop …

    DA: 70 PA: 56 MOZ Rank: 46

  • Pancreatic Cancer Vaccine Plus Immunotherapy and Antibody …

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/newsroom/news-releases/2023/07/pancreatic-cancer-vaccine-plus-immunotherapy-and-antibody-spark-immune-system-response-in-pancreatic-cancers

    WEBJul 17, 2023 · Fast Facts. Combination therapy for #pancreaticcancer by @hopkinskimmel researchers appears promising in a platform trial. Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab and …

    DA: 100 PA: 31 MOZ Rank: 81

  • Significant Advances in Lung Cancer Treatment Bring Hope

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/articles/2022/05/significant-advances-in-lung-cancer-treatment-bring-hope

    WEBMay 5, 2022 · In 2021, there were more than 10 new drugs approved for lung cancer alone. That is astronomical for cancer. With clinical trials available at different stages of disease and different phases of treatment, and so many new approaches, we are providing more hope for our patients.”

    DA: 97 PA: 11 MOZ Rank: 51

  • Circulating Tumor DNA Levels Predict Treatment Outcomes for …

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/newsroom/news-releases/2024/03/circulating-tumor-dna-levels-predict-treatment-outcomes-for-patients-with-gastroesophageal-cancer-treated-with-a-novel-immunotherapy-combination

    WEBMar 19, 2024 · Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for …

    DA: 47 PA: 9 MOZ Rank: 6

  • Johns Hopkins Investigators Develop Novel Treatment for T-cell

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/newsroom/news-releases/2024/04/johns-hopkins-investigators-develop-novel-treatment-for-t-cell-leukemias-and-lymphomas

    WEBApr 2, 2024 · A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective at killing these cancers in mice bearing human T-cell tumors.

    DA: 92 PA: 16 MOZ Rank: 22

  • Novel Immunotherapy Agent Safe, Shows Promise Against High …

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/newsroom/news-releases/2023/04/novel-immunotherapy-agent-safe-shows-promise-against-high-risk-prostate-cancers

    WEBApr 6, 2023 · Fast Facts. Research @hopkinskimmel shows promise for immunotherapy drug against type of prostate cancer. A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by …

    DA: 18 PA: 46 MOZ Rank: 37

  • A Cure for Lung Cancer? | Johns Hopkins Medicine

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/articles/2022/06/a-cure-for-lung-cancer

    WEBBy Amy Mone on 06/04/2022. Published in Hopkins Medicine - Spring/Summer 2022. Patients with resectable lung cancer have long faced bleak prospects. Standard treatment has been to remove the tumor, yet most patients experience a lung cancer recurrence after surgery, and when this happens it usually is incurable.

    DA: 14 PA: 98 MOZ Rank: 30

  • A Paradigm Shift for Prostate Cancer? | Johns Hopkins Medicine

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/articles/2023/05/a-paradigm-shift-for-prostate-cancer

    WEBMay 25, 2023 · A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

    DA: 96 PA: 73 MOZ Rank: 74

  • Liquid Biopsy Predicts Immunotherapy Response and Toxicity in …

    hopkinsmedicine.org

    https://www.hopkinsmedicine.org/news/newsroom/news-releases/2023/12/liquid-biopsy-predicts-immunotherapy-response-and-toxicity-in-patients-with-advanced-lung-cancer

    WEBDec 12, 2023 · By monitoring changes in circulating tumor DNA (ctDNA) among 30 patients treated with immunotherapies for metastatic non-small cell lung cancers, the researchers were able to determine molecular response — the clearance of tumor genetic material in the bloodstream — which was significantly associated with progression-free and overall …

    DA: 55 PA: 68 MOZ Rank: 72